Request Consultation
Download Videssa Guide



Uriel E. Kusiatin, Chief Executive Officer

Uriel E. Kusiatin joined Provista as the Chief Financial Officer in June 2015 after 25 years of strategy development, operational execution and financial management experience as a business consultant and operations executive. Since late 2013, Mr. Kusiatin has been working with Provista Diagnostics on the development of more robust financial systems and controls as well as managing the budgeting, financial planning, and analysis processes.

Mr. Kusiatin began his career at Deloitte in 1996 and has specialized in the life sciences industry - from large international pharmaceutical, biotech and medical device companies to small start-ups - on maximizing significant business and financial opportunities. Mr. Kusiatin has also held interim c-level positions in private and public companies. Mr. Kusiatin holds a Bachelor of Science in Industrial Engineering from the Technical Institute of Denmark and a Masters of Business Administration from the Wharton School of the University of Pennsylvania.


Rao V. Mulpuri, PhD, MBA, Chief Operating Officer

Rao Mulpuri, PhD, MBA was appointed Chief Operating Officer in 2014 with 15 years of experience in molecular diagnostics and genomics industry. Dr. Mulpuri provides executive leadership and strategic direction for the operations of Provista Diagnostics including the scientific, laboratory and business operations, clinical product development, IT and informatics, quality and regulatory compliance.

Before joining Provista, Dr. Mulpuri served as a Vice President of Laboratory Operations for Assurex Health, Inc., where he scaled up the operations and established global clinical laboratories to develop and commercialize molecular diagnostic products.

From 2010 to 2012, Dr. Mulpuri was the Director of Scientific Operations at Catholic Health Initiatives (CHI), a network of 75 community hospitals where he implemented operational, informatics and regulatory strategies to bring genomics (personalized medicine) into the mainstream of healthcare.

Prior to CHI, Dr. Mulpuri served as a Site Head of a CLIA-/GLP-/GMP-compliant Genomics and Clinical testing facility of Beckman Coulter Genomics. During his tenure, he led scientific teams and integrated global business units, established global customer support functions, implemented global e-commerce, CRM and billing systems to develop and commercialize genomic and diagnostic tests in the United States and Europe. Dr. Mulpuri received his Doctorate in Physiology and Biochemistry from Vikram University and a Masters of Business Administration with honors from the University of North Carolina, Chapel Hill at the Kenan-Flagler Business School.



Board of Directors


Advisory Board